Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer

Gastroenterology · Available online 25 May 2026 · In press · Journal article · DOI 10.1053/j.gastro.2026.04.041 · Cited by 1 (Crossref)

Free full text

Authors (17)

Namita Bhyravbhatla, Zahraa W. Alsafwani, Ishwor Thapa, Palanisamy Nallasamy, Pranita Atri, Carlos M. Moran Segura, Margaret A. Park, Imran Khan, Krystal Villalobos-Ayala, Saravanakumar Marimuthu, Jesse L. Cox, Barbara A. Centeno, Abhijit Aithal, Mokenge Malafa, Dario Ghersi, Surinder K. Batra, Sushil Kumar

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume
171
Issue
4
Pages
717-733
Year
2026

Citation

Bhyravbhatla, N., Alsafwani, Z., Thapa, I., et al. (2026). Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer. Gastroenterology. https://doi.org/10.1053/j.gastro.2026.04.041

Related articles

Metrics

Citations (Crossref)
1